According to e-company newsFosun PharmaceuticalsAccording to the news, on August 28, Fosun Pharmaceutical announced that the first small molecule innovative drug, sukoxin® (generic name: avatripopa maleate tablets, “avatripopa tablets” for short) introduced by the company has been launched in 31 provinces, regions and cities across the country, including Beijing, Shanghai, and Guangdong, and the first prescriptions have been issued one after another. Sucoxin® is currently the world's first FDA-approved oral thrombocytopenia (TPO-RA) for CLD-related thrombocytopenia in adult patients undergoing optional diagnostic procedures or surgery.
复星医药：创新药苏可欣“首张处方”在全国31个省区市落地
Fosun Pharmaceuticals: Innovative drug Su Kexin's “first prescription” landed in 31 provinces, regions and cities across the country
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.